Clinical profile and demographic distribution of Fuchs' endothelial dystrophy: An electronic medical record-driven big data analytics from an eye care network in India.
Big data
Fuchs' endothelial dystrophy
India
cornea
electronic medical records
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
entrez:
6
7
2022
pubmed:
7
7
2022
medline:
8
7
2022
Statut:
ppublish
Résumé
To describe the demographics and clinical profile of Fuchs' endothelial corneal dystrophy (FECD) in patients presenting to a multi-tiered ophthalmology hospital network in India. This cross-sectional hospital-based study included 3,082,727 new patients presenting between August 2010 and December 2021. Patients with a clinical diagnosis of FECD in at least one eye were included as cases. The data were collected using an electronic medical record system. Overall, 2570 (0.08%) patients were diagnosed with FECD. The majority of the patients were female (65.53%) and were predominantly adults (99.92%). The most common age group at presentation was during the seventh decade of life with 867 patients (33.74%). The overall prevalence was higher in patients from a higher socioeconomic status (0.1%) presenting from the urban geography (0.09%) and in retired individuals (0.4%). About half of the 5,140 eyes had mild or no visual impairment (< 20/70) in 2643 eyes (51.42%) followed by moderate visual impairment (>20/70 to 20/200) in 708 eyes (13.77%). The average logMAR was 0.61 ± 0.81 at presentation. The most documented corneal signs were guttae (76.63%), corneal scar (23%) and stromal edema (21.73%). The most associated ocular comorbidity was cataract (47.32%) followed by glaucoma (5.39%). More than a tenth of the affected eyes required a surgical intervention of endothelial keratoplasty (15.58%). FECD more commonly affects females presenting during the seventh decade of life. Majority of the eyes had mild or no visual impairment and endothelial keratoplasty is warranted in a tenth of the affected eyes.
Identifiants
pubmed: 35791122
pii: IndianJOphthalmol_2022_70_7_2415_349177
doi: 10.4103/ijo.IJO_755_22
pmc: PMC9426146
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2415-2420Déclaration de conflit d'intérêts
None
Références
Trans Am Ophthalmol Soc. 1933;31:48-59
pubmed: 16692989
Cornea. 2021 May 1;40(5):548-553
pubmed: 32740009
Cornea. 2017 Aug;36(8):e17-e18
pubmed: 28520609
Arch Ophthalmol. 2006 Jun;124(6):777-80
pubmed: 16769829
Mol Diagn Ther. 2019 Feb;23(1):97-112
pubmed: 30607871
Ophthalmic Res. 2002 May-Jun;34(3):135-8
pubmed: 12097795
Indian J Ophthalmol. 2012 Sep-Oct;60(5):396-400
pubmed: 22944748
Jpn J Ophthalmol. 1996;40(4):520-5
pubmed: 9130056
Indian J Ophthalmol. 2020 Mar;68(3):427-432
pubmed: 32056994
Curr Opin Ophthalmol. 2022 Jan 1;33(1):21-27
pubmed: 34743088
Am J Ophthalmol. 1967 Dec;64(6):1155-8
pubmed: 6072991
Int Ophthalmol. 2022 Apr;42(4):1299-1309
pubmed: 34743257
Br J Ophthalmol. 2021 Jan;105(1):17-21
pubmed: 32188677
Ophthalmology. 1979 Oct;86(10):1897-923
pubmed: 399801
Cornea. 1988;7(1):2-18
pubmed: 3280235
Ophthalmology. 2006 Apr;113(4):565-9
pubmed: 16581419
J Pers Med. 2022 Feb 18;12(2):
pubmed: 35207793
Int Ophthalmol. 2021 Oct;41(10):3277-3285
pubmed: 34021829
Ophthalmologe. 2019 Mar;116(3):221-227
pubmed: 30402742